东亚药业：12月9日召开董事会会议

Group 1 - East Asia Pharmaceutical held its fourth board meeting on December 9, 2025, to discuss the revision of the "Audit Committee Working Rules" [1] - The company's revenue composition for the year 2024 is 99.19% from pharmaceutical chemicals and 0.81% from other businesses [1] Group 2 - The market capitalization of East Asia Pharmaceutical is currently 2.2 billion yuan [2]